PharmaShots Weekly Snapshot (Sept 21-25, 2020)
1. Philips Launches QuickClear Mechanical Thrombectomy System for Blood Clot Removal
Published: Sept 25,2020 | Tags: Philips, Launches, QuickClear Mechanical Thrombectomy System, Blood Clot Removal
Published: Sept 25,2020 | Tags: BMS, Reports, Results, Opdivo, (nivolumab), P-III, CheckMate -274 Study, Patients, High-Risk, Muscle-Invasive Urothelial Carcinoma
Published: Sept 25,2020 | Tags: Evaluates, Heart Failure, High Risk, Identify, Insertable Cardiac Monitor, Medtronic, Worsening
Published: Sept 25, 2020 | Tags: Polatuzumab vedotin, approval, Diffuse Large B Cell Lymphoma, Health Canada, Polivy, r/r, receives, Roche
5. Novavax Initiates P-III Study of its COVID-19 Vaccine in the UK
Published: Sept 25, 2020 | Tags: COVID-19, Initiates, Novavax, P-III study, UK, vaccine
6. Accord Launches Zercepac (biosimilar, trastuzumab) in the UK
Published: Sept 25, 2020 | Tags: Accord, Biosimilar, Launches, trastuzumab, UK, Zercepac
7. IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid Tumors Harboring GNAQ or GNA11 Mutations
Published: Sept 24, 2020 | Tags: Collaboration, Expand, GNAQ, Harboring, IDEAYA, Pfizer, Solid Tumors Supply
Published: Sept 24, 2020 | Tags: Verona, Initiates, P-III, ENHANCE Studies, Evaluating, Nebulized Ensifentrine, Maintenance Treatment, COPD
Published: Sept 24, 2020 | Tags: Cognitive Behavioral Therapy, Opioid Use Disorder, Pear Therapeutics, Prescription Digital Therapeutics, RESET, reSET-O, Substance Use Disorder, Us FDA, Wellpath Community Care Centers
10. Genentech and AC Immune's Semorinemab Flounders in P-II TAURIEL Study for Early Alzheimer's Disease
Published: Sept 24, 2020 | Tags: Genentech, AC Immune, Semorinemab, Flounders, P-II, TAURIEL Study, Early Alzheimer's disease
11. Novartis and Siemens Collaborate to Develop Blood Tests for Multiple Sclerosis
Published: Sept 24, 2020 | Tags: Blood Tests, Collaborate, Develop, Multiple Sclerosis, Novartis, Siemens
12. J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine
Published: Sept 24, 2020 | Tags: Ad26.COV2. S, Clinical Study, COVID-19, Global, Initiates, J&J, JNJ-78436735, P-III, vaccine
Published: Sept 23, 2020 | Tags: Biomarker-Driven Therapy, Metastatic NSCLC, Pediatric ALK-Positive Anaplastic Large Cell Lymphoma, Pfizer, Supplemental New Drug Application, Tyrosine Kinase Inhibitor, Us FDA, Xalkori
14. Sanofi's Supemtek Receives CHMP's Positive Opinion for Approval to Prevent Influenza
Published: Sept 23, 2020 | Tags: Approval, CHMP, Influenza, Positive Opinion, Sanofi, Supemtek
Published: Sept 23, 2020 | Tags: Atopic Dermatitis, Cutaneous T-cell Lymphoma, Diabetic Wound Infections, Dosing, Endolysin, Micreos, MRSA, S. aureus, XZ.700
Published: Sept 23, 2020 | Tags: Acceptance, BLA, Bluebird Bio, BMS, FDA, Idecabtagene Vicleucel, Multiple Myeloma, Priority Review, Report
Published: Sept 23, 2020 | Tags: Novartis, Initiate, Pivotal Confirmatory Study, AVXS-101, Intrathecal Formulation, Patients with SMA
Published: Sept 23, 2020 | Tags: Acceptance, EMA, Bimekizumab, BLA, FDA, MAA, Moderate, Plaque Psoriasis, UCB
19. BMS Inrebic (fedratinib) Receives Health Canada's Approval for Patients with Myelofibrosis
Published: Sept 22, 2020 | Tags: Fedratinib, Approval, BMS, Health Canada, Inrebic, Myelofibrosis
20. Illumina to Acquire GRAIL for ~$8B
Published: Sept 22, 2020 | Tags: Acquire, GRAIL, Illumina, $8B
Published: Sept 22, 2020 | Tags: Ravulizumab, Alexion, CHMP, New Advanced Formulation, Positive Opinion, Ultomiris
22. Genentech Collaborates with Scenic Biotech to Develop Novel Therapies Targeting Genetic Modifiers
Published: Sept 22, 2020 | Tags: Collaborates, Develop, Genentech, Genetic Modifiers, Novel Therapies, Scenic Biotech, Targeting
23. Novartis Kisqali (ribociclib) Receives Highest Score on the ESMO Magnitude of Clinical Benefit Scale
Published: Sept 22, 2020 | Tags: Novartis, Kisqali, (ribociclib), Receives, Highest Score, ESMO Magnitude of Clinical Benefit Scale, MONALEESA-7, MONALEESA-3, CDK 4/6 inhibitor
Published: Sept 21, 2020 | Tags: Baricitinib, Atopic Dermatitis, CHMP, Lilly, Moderate to Severe, Olumiant, Positive Opinion, Receives
Published: Sept 21, 2020 | Tags: Roche, Presents, New, P-III, Data, Tecentriq, Triple-Negative Breast Cancer, ESMO Virtual Congress 2020
26. Bausch Health Acquires Option to Purchase Allegro's Ophthalmology Assets
Published: Sept 21, 2020 | Tags: Acquires, Allegro, Bausch Health, Ophthalmology Assets, Option to Purchase
Published: Sept 21, 2020 | Tags: Olaparib, Advanced Ovarian Cancer, AstraZeneca, CHMPs Positive Opinion, HRD-Positive, Lynparza, Maintenance Treatment, MSD
28. Roche Acquires Inflazome for ~$450M
Published: Sept 21, 2020 | Tags: Roche, Acquire, Inflazome, $450M
29. Takeda Collaborates with Foundation Medicine for Lung Cancer CDx
Published: Sept 21, 2020 | Tags: Takeda, Collaborates, Foundation Medicine, Lung Cancer, CDx
Published: Sept 21, 2020 | Tags: ADAURA Study, Adjuvant, AstraZeneca, Early-Stage, EGFR-Mutated, Lung Cancer, Osimertinib, P-III, Patients, Reports, Results, Tagrisso, Treatment
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com